Associated Papers
Exploring Possible Drug-Resistant Variants of SARS-CoV-2 Main Protease (Mpro) with Noncovalent Preclinical Candidate, Mpro61.
Kenneson JR et al.
Acs Bio & Med Chem Au, 2025
SARS-CoV-2 Resistance to Small Molecule Inhibitors.
Lopez UM et al.
Current Clinical Microbiology Reports, 2024
Distal Protein-Protein Interactions Contribute to SARS-CoV-2 Main Protease Substrate Binding and Nirmatrelvir Resistance.
Lewandowski EM et al.
Biorxiv : the Preprint Server for Biology, 2024
Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease.
Flynn JM et al.
Acs Infectious Diseases, 2023
Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes.
Padhi AK et al.
Biochemical and Biophysical Research Communications, 2022
Select a paper to view details